A Proteogenomic Approach to Discover Novel lncRNA-Derived Microproteins and Their Potential Clinical Utility in Hepatocellular Carcinoma
Molecular & Cellular Proteomics · 2026-06 · 25 (6) · 101584
DOI: 10.1016/j.mcpro.2026.101584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2026-06. Verfasst von Bingwu Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biology Program, Division of Science, New York University Abu Dhabi, Abu Dhabi, UAE. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Proteogenomics, RNA, Long Noncoding. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New York University - Abu Dhabi.
Abstract (Originalsprache)
Microproteins (i.e., peptides) are increasingly recognized for their functions in versatile biological contexts, but their clinical relevance and utility remain largely unexplored. Proteogenomic approaches can accelerate microprotein discovery in clinical samples by integrating proteomic data with genomics and transcriptomics evidence. However, long noncoding RNA (lncRNA)-derived microproteins (lncPeps) remain largely unidentified, resulting in unmatchable MS/MS spectra. To solve this problem, we have used high-quality Ribo-seq translatomic datasets to generate an extensive database of human liver lncRNA-derived open reading frames (lncORFs), which we subsequently applied to proteomics data of tumor-adjacent normal tissue pairs from hepatocellular carcinoma (HCC) patients. Using the new database, we discovered 104 novel lncPeps, including 46 lncPeps differentially expressed between tumor and nontumor tissues, and 13 lncPeps with significant correlation with prognosis. Remarkably, combining the expression of lncPeps with canonical proteins in a LASSO regression model improved predictive performance for recurrence, increasing the AUC by 0.005 to 0.085 across three recurrence time points. These findings suggest that the discovery of lncPeps contributes to our understanding of the molecular heterogeneity and progression of HCC and broadens the range of potential biomarker candidates and treatment targets for the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biology Program, Division of Science, New York University Abu Dhabi, Abu Dhabi, UAE.
- Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA; Johns Hopkins All Children's Hospital, St Petersburg, Florida, USA.
- Biology Program, Division of Science, New York University Abu Dhabi, Abu Dhabi, UAE. Electronic address: ohtan.wang@nyu.edu.
Förderung
- New York University - Abu Dhabi
Zitieren
APA
Li, B., Joshi, K., & Wang, D. O. (2026). A Proteogenomic Approach to Discover Novel lncRNA-Derived Microproteins and Their Potential Clinical Utility in Hepatocellular Carcinoma. Molecular & Cellular Proteomics, 25(6), 101584. https://doi.org/10.1016/j.mcpro.2026.101584
Vancouver
Li B, Joshi K, Wang DO. A Proteogenomic Approach to Discover Novel lncRNA-Derived Microproteins and Their Potential Clinical Utility in Hepatocellular Carcinoma. Molecular & Cellular Proteomics. 2026;25(6):101584. doi:10.1016/j.mcpro.2026.101584
BibTeX
@article{Li2026,
author = {Li, Bingwu and Joshi, Kandarp and Wang, Dan Ohtan},
title = {A Proteogenomic Approach to Discover Novel lncRNA-Derived Microproteins and Their Potential Clinical Utility in Hepatocellular Carcinoma},
journal = {Molecular & Cellular Proteomics},
year = {2026},
volume = {25},
number = {6},
pages = {101584},
doi = {10.1016/j.mcpro.2026.101584}
}
EUVIMED